ZBIO Zenas BioPharma, Inc.

Fundamentals / CIK 0001953926 / USD

Zenas BioPharma, Inc. reported $10.00M in revenue and a net loss of $541.8M for the fiscal year ended December 31, 2025 (up 100.0% year over year), with a -5264.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ZBIO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$89.17M$44.58M$0-$357.4MFY 2023 Revenue: $50.00MFY 2023 Net Income: -$37.12M2023FY 2024 Revenue: $5.00MFY 2024 Net Income: -$157.0M2024FY 2025 Revenue: $10.00MFY 2025 Net Income: -$377.7M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue $10.00M $5.00M $50.00M
Research & Development $168.1M $139.1M $60.03M
Total Operating Expenses $393.1M $168.9M $87.15M
Operating Income -$383.1M -$163.9M -$37.15M
EBITDA -$383.0M -$163.8M -$37.03M
Interest Income $12.15M $7.97M --
Interest Expense $7.33M -- --
Income Before Tax -$377.8M -$156.6M -$36.82M
Income Tax Expense -$79K $429K $301K
Net Income -$377.7M -$157.0M -$37.12M
Basic EPS -$8.44 -$11.89 -$24.25
Diluted EPS -$8.44 -$11.89 -$24.25
Basic Shares Outstanding 44.7M 13.2M 1.5M
Diluted Shares Outstanding 44.7M 13.2M 1.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $10.00M $1.00M -- $0 $0 $0 $10.00M --
Research & Development $58.47M $62.91M $60.44M $55.72M $34.40M $43.03M $34.91M $49.16M
Total Operating Expenses $113.4M $108.7M $77.35M $238.0M $52.58M $55.16M $47.33M $60.62M
Operating Income -$103.4M -$107.7M -$77.35M -$238.0M -$52.58M -$55.16M -$37.33M -$55.62M
EBITDA -$103.4M -$107.7M -$77.34M -$238.0M -$52.57M -$55.15M -$37.31M -$55.59M
Interest Income $5.79M $6.60M $3.02M $3.25M $2.77M $2.74M $3.39M --
Interest Expense $2.06M $1.72M $368K -- -- -- -- --
Income Before Tax -$108.9M -$111.3M -$80.99M -$240.3M -$51.50M -$52.20M -$33.78M -$52.17M
Income Tax Expense $49K $114K -- $106K $0 $20K -$205K --
Net Income -$108.9M -$111.5M -$80.99M -$240.4M -$51.50M -$52.22M -$33.57M -$52.60M
Basic EPS -$1.65 -$1.77 -$1.46 -- -$1.22 -$1.25 -$0.80 --
Diluted EPS -$1.65 -$1.77 -$1.46 -- -$1.22 -$1.25 -$0.80 --
Basic Shares Outstanding 66.1M 63.1M 55.6M -- 42.2M 41.9M 41.8M --
Diluted Shares Outstanding 66.1M 63.1M 55.6M -- 42.2M 41.9M 41.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $110.6M $319.7M $56.86M
Short-Term Investments $232.6M $31.02M --
Cash & Short-Term Investments $360.5M $350.8M $56.86M
Total Current Assets $351.2M $355.9M $59.80M
Property, Plant & Equipment, Net $34K $185K $193K
Long-Term Investments $17.27M -- --
Other Non-Current Assets $13.81M $12.86M $7.28M
Total Non-Current Assets $32.47M $14.04M $8.38M
Total Assets $383.6M $370.0M $68.18M
Accounts Payable $7.11M $17.14M $5.40M
Total Current Liabilities $62.65M $57.29M $23.26M
Long-Term Debt $78.64M -- --
Total Non-Current Liabilities $78.85M $218K $20.56M
Total Liabilities $141.5M $57.51M $43.81M
Total Debt (incl. Leases) $79.96M $1.00M $813K
Common Stock $5.0K $4.0K --
Retained Earnings -$765.1M -$387.4M -$230.4M
Accumulated Other Comp. Income -$64K $194K $37K
Total Stockholders' Equity $242.1M $312.5M -$225.7M
Total Equity $242.1M $312.5M -$225.7M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $177.8M $196.6M $500.2M $110.6M $115.6M $44.01M $196.6M $319.7M
Short-Term Investments $407.5M $446.5M $217.0M $232.6M $175.3M $229.3M $115.8M $31.02M
Cash & Short-Term Investments $647.1M $673.9M $718.5M $360.5M $301.6M $274.9M $314.2M $350.8M
Total Current Assets $603.4M $653.8M $730.2M $351.2M $296.6M $278.6M $317.8M $355.9M
Property, Plant & Equipment, Net $19K $23K $28K $34K $50K $61K $72K $185K
Long-Term Investments $61.77M $30.76M $1.34M $17.27M $10.72M $1.61M $1.83M --
Other Non-Current Assets $8.39M $16.29M $15.06M $13.81M $13.80M $11.80M $12.85M $12.86M
Total Non-Current Assets $71.77M $47.90M $17.52M $32.47M $25.38M $14.48M $15.96M $14.04M
Total Assets $675.2M $701.7M $747.7M $383.6M $322.0M $293.1M $333.8M $370.0M
Accounts Payable $7.06M $7.59M $8.94M $7.11M $6.44M $7.93M $20.02M $17.14M
Deferred Revenue (Current) $2.03M -- -- -- -- -- -- --
Total Current Liabilities $64.04M $65.82M $61.16M $62.65M $52.42M $53.24M $49.13M $57.29M
Long-Term Debt -- -- -- $78.64M $72.99M -- -- --
Total Non-Current Liabilities $398.9M $388.8M $350.7M $78.85M $73.17M $215K $317K $218K
Total Liabilities $462.9M $454.6M $411.9M $141.5M $125.6M $53.46M $49.45M $57.51M
Total Debt (incl. Leases) $1.54M $845K $1.11M $79.96M $73.79M $1.01M $1.23M $1.00M
Common Stock $7.0K $6.0K $6.0K $5.0K $4.0K $4.0K $4.0K $4.0K
Retained Earnings -$1.07B -$957.6M -$846.1M -$765.1M -$524.7M -$473.2M -$421.0M -$387.4M
Accumulated Other Comp. Income -$1.26M -$1.14M -$377K -$64K -$69K -$94K $141K $194K
Total Stockholders' Equity $212.3M $247.1M $335.8M $242.1M $196.4M $239.6M $284.3M $312.5M
Total Equity $212.3M $247.1M $335.8M $242.1M $196.4M $239.6M $284.3M $312.5M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$377.7M -$157.0M -$37.12M
Depreciation & Amortization $56K $137K $113K
Stock-Based Compensation $26.35M $10.82M $3.50M
Change in Payables -$10.04M $11.74M -$418K
Operating Cash Flow -$172.3M -$119.7M -$30.53M
Capital Expenditure -$18K -$131K -$17K
Free Cash Flow -$172.4M -$119.8M -$30.55M
Purchases of Investments -$417.8M -$36.42M --
Sales & Maturities of Investments $200.9M $6.00M --
Investing Cash Flow -$251.9M -$30.55M -$17K
Financing Cash Flow $215.3M $413.0M $20.12M
Net Change in Cash -$209.2M $262.9M -$10.35M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$108.9M -$111.5M -$80.99M -$240.4M -$51.50M -$52.22M -$33.57M -$52.60M
Depreciation & Amortization $4.0K $4.0K $6.0K $10K $11K $12K $23K $33K
Stock-Based Compensation $17.28M $8.62M $9.20M $7.58M $7.34M $6.04M $5.39M $5.50M
Change in Payables -$514K -$1.33M $1.79M $1.12M -$1.95M -$12.09M $2.88M $5.42M
Operating Cash Flow -$57.98M -$57.24M -$75.20M -$52.41M -$41.12M -$41.74M -$37.05M -$38.55M
Capital Expenditure -$1.0K $0 -$2.0K $0 $0 $0 -$18K -$74K
Free Cash Flow -$57.98M -$57.24M -$75.20M -$52.41M -$41.12M -$41.74M -$37.07M -$38.63M
Purchases of Investments -$137.5M -$331.8M -$76.52M -$132.9M -$59.20M -$126.6M -$99.11M --
Sales & Maturities of Investments $145.8M $74.11M $108.1M $69.53M $104.2M $14.26M $12.86M --
Investing Cash Flow -$19.21M -$287.7M $31.61M -$93.36M $40.04M -$112.3M -$86.27M -$3.73M
Financing Cash Flow $57.21M $42.06M $433.5M $140.8M $72.62M $1.72M $99K $1.85M
Net Change in Cash -$18.80M -$303.6M $389.6M -$4.92M $71.56M -$152.5M -$123.3M -$40.30M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Operating Margin -3830.6% -3277.8% -74.3%
Net Profit Margin -3777.4% -3139.8% -74.2%
Return on Equity (ROE) -156.0% -50.2% --
Return on Assets (ROA) -98.5% -42.4% -54.4%
Current Ratio 5.61x 6.21x 2.57x
Quick Ratio 5.75x 6.12x 2.44x
Debt to Equity 0.33x 0.00x --
Revenue Growth (YoY) +100.0% -90.0% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -3830.6% -- -- -- --
Net Profit Margin -- -- -- -3777.4% -- -- -- --
Return on Equity (ROE) -255.2% -196.0% -126.6% -156.0% -96.7% -73.9% -57.2% -50.2%
Return on Assets (ROA) -80.2% -69.0% -56.9% -98.5% -59.0% -60.4% -48.8% -42.4%
Current Ratio 9.42x 9.93x 11.94x 5.61x 5.66x 5.23x 6.47x 6.21x
Quick Ratio 10.10x 10.24x 11.75x 5.75x 5.75x 5.16x 6.40x 6.12x
Debt to Equity 0.01x 0.00x 0.00x 0.33x 0.38x 0.00x 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001953926) · from March 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:23 UTC · Open in terminal